To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

This means that many patients do not respond to current immunotherapies ... The study showed that T-cells from liver fluid had profiles indicating both central memory function and cytotoxic ...

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

Immatics is a clinical-stage biopharmaceutical company at the forefront of the discovery and development of T cell–based immunotherapies to treat cancer. Its mission is to open new therapeutic ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune ... targeting DDX54 promoted the differentiation of T cells and memory T cells that suppress tumors, while reducing ...

Immune checkpoint inhibitors, a class of immunotherapies ... central regulator in the immune evasion of lung cancer cells. In a syngeneic mouse model, the suppression of DDX54 led to significant ...